ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma
Celgene
Grzegorz S Nowakowski; Annalisa Chiappella; Randy D Gascoyne; David W Scott; Qingyuan Zhang; Wojciech Jurczak; Muhit Özcan; Xiaonan Hong; Jun Zhu; Jie Jin; David Belada; Juan Miguel Bergua; Francesco Piazza; Heidi Mócikova; Anna Lia Molinari; Dok Hyun Yoon; Federica Cavallo; Monica Tani; Kazuhito Yamamoto; Koji Izutsu; Koji Kato; Myron Czuczman; Sarah Hersey; Adrian Kilcoyne; Jacqueline Russo; Krista Hudak; Jingshan Zhang; Steve Wade; Thomas E Witzig; Umberto Vitolo
Department of Statistical Programming, Celgene Corporation, Overland Park, KS.